HRP20090036T3 - Novel pyridopyrazines and use thereof as kinase modulators - Google Patents
Novel pyridopyrazines and use thereof as kinase modulatorsInfo
- Publication number
- HRP20090036T3 HRP20090036T3 HR20090036T HRP20090036T HRP20090036T3 HR P20090036 T3 HRP20090036 T3 HR P20090036T3 HR 20090036 T HR20090036 T HR 20090036T HR P20090036 T HRP20090036 T HR P20090036T HR P20090036 T3 HRP20090036 T3 HR P20090036T3
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- cycloalkyl
- heterocyclyl
- Prior art date
Links
- YEYHFKBVNARCNE-UHFFFAOYSA-N pyrido[2,3-b]pyrazine Chemical class N1=CC=NC2=CC=CN=C21 YEYHFKBVNARCNE-UHFFFAOYSA-N 0.000 title abstract 2
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- -1 alkyl radical Chemical class 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052740 iodine Inorganic materials 0.000 abstract 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
- 229910004727 OSO3H Inorganic materials 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 229910006069 SO3H Inorganic materials 0.000 abstract 1
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 1
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 abstract 1
- 125000005213 alkyl heteroaryl group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 150000005840 aryl radicals Chemical class 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10323345A DE10323345A1 (de) | 2003-05-23 | 2003-05-23 | Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren |
DE102004022383A DE102004022383A1 (de) | 2004-05-06 | 2004-05-06 | Neue Pyridopyrazine und deren Verwendung als Modulatoren von Kinasen |
PCT/EP2004/005388 WO2004104003A1 (de) | 2003-05-23 | 2004-05-19 | Neue pyridopyrazine und deren verwendung als modulatoren von kinasen |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090036T3 true HRP20090036T3 (en) | 2009-03-31 |
Family
ID=33477517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20090036T HRP20090036T3 (en) | 2003-05-23 | 2009-01-21 | Novel pyridopyrazines and use thereof as kinase modulators |
Country Status (26)
Country | Link |
---|---|
US (1) | US7276507B2 (uk) |
EP (1) | EP1636228B1 (uk) |
JP (2) | JP4571944B2 (uk) |
KR (1) | KR101111464B1 (uk) |
AR (1) | AR045686A1 (uk) |
AT (1) | ATE411992T1 (uk) |
AU (1) | AU2004240747B2 (uk) |
BR (1) | BRPI0410633A (uk) |
CA (1) | CA2524525C (uk) |
CY (1) | CY1108715T1 (uk) |
DE (1) | DE502004008322D1 (uk) |
DK (1) | DK1636228T3 (uk) |
ES (1) | ES2316985T3 (uk) |
HK (1) | HK1090643A1 (uk) |
HR (1) | HRP20090036T3 (uk) |
ME (1) | ME00541B (uk) |
MX (1) | MXPA05012645A (uk) |
NO (1) | NO332005B1 (uk) |
NZ (1) | NZ544112A (uk) |
PL (1) | PL1636228T3 (uk) |
PT (1) | PT1636228E (uk) |
RU (1) | RU2330851C9 (uk) |
SI (1) | SI1636228T1 (uk) |
TW (1) | TWI341839B (uk) |
UA (1) | UA78929C2 (uk) |
WO (1) | WO2004104003A1 (uk) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7589068B2 (en) * | 2005-02-14 | 2009-09-15 | Merck & Co., Inc. | Inhibitors of Akt activity |
US8217042B2 (en) | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
EP1790342A1 (de) * | 2005-11-11 | 2007-05-30 | Zentaris GmbH | Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege |
EP1957487A1 (de) * | 2005-11-11 | 2008-08-20 | AEterna Zentaris GmbH | Neue pyridopyrazine und deren verwendung als modulatoren von kinasen |
EP1785423A1 (de) * | 2005-11-11 | 2007-05-16 | Zentaris GmbH | Neue Pyridopyrazine und deren Verwendung als Modulatoren von Kinasen |
JO2985B1 (ar) | 2006-12-20 | 2016-09-05 | Takeda Pharmaceuticals Co | مثبطات كينازmapk/erk |
EP1990342A1 (en) * | 2007-05-10 | 2008-11-12 | AEterna Zentaris GmbH | Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof |
CA2774999A1 (en) | 2009-09-30 | 2011-04-07 | President And Fellows Of Harvard College | Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
GB201007286D0 (en) | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
GB201020179D0 (en) | 2010-11-29 | 2011-01-12 | Astex Therapeutics Ltd | New compounds |
EP2508184A1 (en) | 2011-04-06 | 2012-10-10 | Æterna Zentaris GmbH | Pyridopyrazine derivatives and their use |
GB201118656D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118652D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118675D0 (en) | 2011-10-28 | 2011-12-14 | Astex Therapeutics Ltd | New compounds |
GB201118654D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201209609D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
GB201209613D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
GB201307577D0 (en) | 2013-04-26 | 2013-06-12 | Astex Therapeutics Ltd | New compounds |
LT3122359T (lt) | 2014-03-26 | 2021-03-25 | Astex Therapeutics Ltd. | Fgfr inhibitoriaus ir igf1r inhibitoriaus deriniai |
SI3122358T1 (sl) | 2014-03-26 | 2021-04-30 | Astex Therapeutics Ltd. | Kombinacije FGFR- in CMET-inhibitorjev za zdravljenje raka |
JO3512B1 (ar) | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز |
JOP20200201A1 (ar) | 2015-02-10 | 2017-06-16 | Astex Therapeutics Ltd | تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين |
US10478494B2 (en) | 2015-04-03 | 2019-11-19 | Astex Therapeutics Ltd | FGFR/PD-1 combination therapy for the treatment of cancer |
EP3353177B1 (en) | 2015-09-23 | 2020-06-03 | Janssen Pharmaceutica NV | Tricyclic heterocycles for the treatment of cancer |
RU2747644C2 (ru) | 2015-09-23 | 2021-05-11 | Янссен Фармацевтика Нв | Бигетероарил-замещенные 1,4-бензодиазепины и пути их применения для лечения рака |
US11117894B2 (en) | 2017-06-22 | 2021-09-14 | City Of Hope | Pyridopyrazine compounds and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9413975D0 (en) * | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
TW274550B (uk) * | 1992-09-26 | 1996-04-21 | Hoechst Ag | |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
UA71555C2 (en) * | 1997-10-06 | 2004-12-15 | Zentaris Gmbh | Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives |
EP1429765A2 (en) | 2001-09-14 | 2004-06-23 | Methylgene, Inc. | Inhibitors of histone deacetylase |
US20060142178A1 (en) * | 2002-04-08 | 2006-06-29 | Barnett Stanley F | Method of treating cancer |
CA2480880C (en) | 2002-04-08 | 2011-03-22 | Merck & Co., Inc. | Inhibitors of akt activity |
EP1496896A4 (en) | 2002-04-08 | 2007-10-31 | Merck & Co Inc | AKT INHIBITORS EFFECT |
WO2004005472A2 (en) | 2002-07-02 | 2004-01-15 | Southern Research Institute | Inhibitors of ftsz and uses thereof |
EP1549614A4 (en) | 2002-10-03 | 2008-04-16 | Targegen Inc | VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION |
DE10323345A1 (de) * | 2003-05-23 | 2004-12-16 | Zentaris Gmbh | Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren |
-
2004
- 2004-05-19 ES ES04733768T patent/ES2316985T3/es not_active Expired - Lifetime
- 2004-05-19 WO PCT/EP2004/005388 patent/WO2004104003A1/de active Application Filing
- 2004-05-19 CA CA2524525A patent/CA2524525C/en not_active Expired - Fee Related
- 2004-05-19 RU RU2005140377/04A patent/RU2330851C9/ru not_active IP Right Cessation
- 2004-05-19 EP EP04733768A patent/EP1636228B1/de not_active Expired - Lifetime
- 2004-05-19 PL PL04733768T patent/PL1636228T3/pl unknown
- 2004-05-19 JP JP2006529872A patent/JP4571944B2/ja not_active Expired - Fee Related
- 2004-05-19 AU AU2004240747A patent/AU2004240747B2/en not_active Ceased
- 2004-05-19 MX MXPA05012645A patent/MXPA05012645A/es active IP Right Grant
- 2004-05-19 ME MEP-2008-831A patent/ME00541B/me unknown
- 2004-05-19 PT PT04733768T patent/PT1636228E/pt unknown
- 2004-05-19 NZ NZ544112A patent/NZ544112A/en unknown
- 2004-05-19 UA UAA200510686A patent/UA78929C2/uk unknown
- 2004-05-19 KR KR1020057022424A patent/KR101111464B1/ko not_active IP Right Cessation
- 2004-05-19 BR BRPI0410633-4A patent/BRPI0410633A/pt not_active IP Right Cessation
- 2004-05-19 AT AT04733768T patent/ATE411992T1/de active
- 2004-05-19 DK DK04733768T patent/DK1636228T3/da active
- 2004-05-19 DE DE502004008322T patent/DE502004008322D1/de not_active Expired - Lifetime
- 2004-05-19 SI SI200431009T patent/SI1636228T1/sl unknown
- 2004-05-20 TW TW093114324A patent/TWI341839B/zh not_active IP Right Cessation
- 2004-05-21 AR ARP040101772A patent/AR045686A1/es not_active Application Discontinuation
- 2004-05-21 US US10/851,976 patent/US7276507B2/en not_active Expired - Fee Related
-
2005
- 2005-12-19 NO NO20056032A patent/NO332005B1/no not_active IP Right Cessation
-
2006
- 2006-10-18 HK HK06111425.6A patent/HK1090643A1/xx not_active IP Right Cessation
-
2009
- 2009-01-21 CY CY20091100081T patent/CY1108715T1/el unknown
- 2009-01-21 HR HR20090036T patent/HRP20090036T3/xx unknown
-
2010
- 2010-07-01 JP JP2010150895A patent/JP5447855B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20090036T3 (en) | Novel pyridopyrazines and use thereof as kinase modulators | |
RS51906B (sr) | Novi piridopirazini i njihova upotreba kao modulatora kinaza | |
AR056216A1 (es) | Derivados de piridopirazina y su uso | |
AR085844A1 (es) | Derivados de piridopirazina y sus usos | |
US3907769A (en) | Azo compounds containing a 2,6-diaminopyridine coupler component | |
CN101479271B (zh) | 长波长偏移的苯并三唑uv吸收剂及其用途 | |
GB1095829A (en) | Water-insoluble mono-azo dyestuffs | |
JPH06104665B2 (ja) | スルホン酸基含有ペリレン化合物、その製造方法およびその用途 | |
CA2244393A1 (en) | Quinoxaline-monoazo-acetarylide pigment | |
JPH02305861A (ja) | 顔料調製物及びこれを含有する印刷インキ及びラツカー | |
KR920018158A (ko) | 디옥사진 화합물을 기본으로 하는 신규한 안료 제제 | |
YU45923B (sh) | Novi derivati pirola | |
EP1087005B1 (en) | Fluorescent diketopyrrolopyrroles | |
YU62991A (sh) | Karbapenemska jedinjenja | |
DE59705203D1 (de) | Wasserlösliche polymerisate und deren verwendung in kosmetischen formulierungen | |
ATE260955T1 (de) | Schwarzfärbende tinten und ihre verwendung | |
TR200001467T2 (tr) | Tiyeno[2,3-d]pirimidin-4-ON'dan oluşan fungisidal kombinasyonlar. | |
US6355795B1 (en) | Triphendioxazine compounds | |
US3870696A (en) | Benzthiazole-azo-(4-n-sulfopropyl)phenyl compounds | |
CA2136914A1 (en) | Pigment composition of a modified diketopyrrolopyrrole and an aminoalkl acrylate resin | |
WO2007017425A3 (en) | Reactive dyes, their preparation and their use | |
KR100480810B1 (ko) | 염 형성 아조 안료 및 1,4-디케토-3,6-디아릴피롤로(3,4-c)피롤을 함유하는 착색제 블렌드 | |
GB1578988A (en) | Mixtures of 1:2 cobalt complexes of azo dyes | |
ES423489A1 (es) | Un procedimiento para la preparacion de nuevas ftalociani- nas. | |
US4031073A (en) | Monoazo pigments containing barbituric acid or thio- or imino-derivatives thereof |